Kyle D. Pedro

420 total citations
7 papers, 101 citations indexed

About

Kyle D. Pedro is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kyle D. Pedro has authored 7 papers receiving a total of 101 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Kyle D. Pedro's work include CAR-T cell therapy research (3 papers), HIV Research and Treatment (2 papers) and Immunotherapy and Immune Responses (2 papers). Kyle D. Pedro is often cited by papers focused on CAR-T cell therapy research (3 papers), HIV Research and Treatment (2 papers) and Immunotherapy and Immune Responses (2 papers). Kyle D. Pedro collaborates with scholars based in United States, Canada and China. Kyle D. Pedro's co-authors include Luis M. Agosto, Andrew J. Henderson, Juan I. Fuxman Bass, Jared Allan Sewell, Xianbao He, Michael LeBlanc, Derek Thirstrup, Michael D. Taylor, Joyoti Dey and David Shih and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Annals of Oncology.

In The Last Decade

Kyle D. Pedro

7 papers receiving 101 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kyle D. Pedro United States	5	43	41	32	23	13	7	101
Meaghan Flagg United States	5	75 1.7×	44 1.1×	34 1.1×	41 1.8×	6 0.5×	10	175
Katharine M. Jenike United States	6	66 1.5×	86 2.1×	40 1.3×	64 2.8×	5 0.4×	10	168
Louisa Helms United States	2	82 1.9×	47 1.1×	50 1.6×	24 1.0×	16 1.2×	2	141
Julia Wegner Germany	4	63 1.5×	45 1.1×	42 1.3×	25 1.1×	4 0.3×	6	117
Yelizaveta Rassadkina United States	6	27 0.6×	54 1.3×	34 1.1×	33 1.4×	3 0.2×	7	98
Mark Berrong United States	6	97 2.3×	57 1.4×	79 2.5×	26 1.1×	20 1.5×	8	191
Annika Niehrs Germany	6	16 0.4×	53 1.3×	83 2.6×	19 0.8×	5 0.4×	6	117
Joshua Mills United States	5	37 0.9×	39 1.0×	37 1.2×	17 0.7×	3 0.2×	7	96
Timothy G. Wanninger United States	5	48 1.1×	58 1.4×	29 0.9×	36 1.6×	7 0.5×	9	117
Nandhini Raman United States	5	64 1.5×	42 1.0×	74 2.3×	17 0.7×	8 0.6×	7	153

Countries citing papers authored by Kyle D. Pedro

Since Specialization

Citations

This map shows the geographic impact of Kyle D. Pedro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle D. Pedro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle D. Pedro more than expected).

Fields of papers citing papers by Kyle D. Pedro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle D. Pedro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle D. Pedro. The network helps show where Kyle D. Pedro may publish in the future.

Co-authorship network of co-authors of Kyle D. Pedro

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle D. Pedro. A scholar is included among the top collaborators of Kyle D. Pedro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle D. Pedro. Kyle D. Pedro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Burga, Rachel A., Bülent Arman Aksoy, Zheng Ao, et al.. (2025). IL-2-independent expansion, persistence, and antitumor activity in TIL expressing regulatable membrane-bound IL-15. Molecular Therapy. 33(8). 3605–3623. 4 indexed citations

2.

Pedro, Kyle D., Rachel A. Burga, Gauri Kulkarni, et al.. (2023). Abstract LB096: IL15-engineered tumor infiltrating lymphocytes (cytoTIL15TM) exhibit activity against autologous tumor cells from multiple solid tumor indications without IL2. Cancer Research. 83(8_Supplement). LB096–LB096. 4 indexed citations

3.

Tchaicha, Jeremy H., Rachel A. Burga, Benjamin Primack, et al.. (2022). Abstract LB212: Allogeneic, IL-2-independent tumor-infiltrating lymphocytes expressing membrane-bound IL-15 (cytoTIL15) eradicate tumors in a melanoma PDX model through recognition of shared tumor antigens. Cancer Research. 82(12_Supplement). LB212–LB212. 1 indexed citations

4.

Pedro, Kyle D., Luis M. Agosto, Jared Allan Sewell, et al.. (2021). A functional screen identifies transcriptional networks that regulate HIV-1 and HIV-2. Proceedings of the National Academy of Sciences. 118(11). 22 indexed citations

5.

Burga, Rachel A., Kyle D. Pedro, Jacques P. Tremblay, et al.. (2021). 1008P cytoTIL15: A novel TIL therapy for melanoma with superior potency and enhanced persistence without IL2 to improve safety & efficacy and expand patient eligibility. Annals of Oncology. 32. S852–S852. 1 indexed citations

6.

Pedro, Kyle D., Andrew J. Henderson, & Luis M. Agosto. (2019). Mechanisms of HIV-1 cell-to-cell transmission and the establishment of the latent reservoir. Virus Research. 265. 115–121. 46 indexed citations

7.

Dey, Joyoti, Adrian M. Dubuc, Kyle D. Pedro, et al.. (2013). MyoD Is a Tumor Suppressor Gene in Medulloblastoma. Cancer Research. 73(22). 6828–6837. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact